Skip to main content
logo
AXIM Biotechnologies, Inc. (AXIM)
OTCMKTS · Delayed Price · Currency is USD
0.0035
-0.0002 (-5.41%)
Sep 29, 2026, 2:47 PM EST

AXIM Biotechnologies Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingJun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Revenue
0.090.040.010.06--
Revenue Growth
257.95%345.27%-85.32%---
Gross Profit
0.090.040.010.06--
Operating Income
-2.31-2.75-4.65-8.01-4.95-3.11
Net Income
-4.14-8.06-6.24-16.03-6.41-6.45
Earnings Per Share
-0.02-0.04-0.04-0.12-0.06-0.11
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingJun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Cash & Investments
0.010.160.050.450.460.73
Total Debt
6.785.895.696.756.345.1
Net Cash (Debt)
-6.78-5.74-5.64-6.3-5.88-4.37
Net Cash Growth
------
Net Cash Per Share
-0.03-0.03-0.03-0.05-0.05-0.07

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingJun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Operating Cash Flow
-0.76-1.03-2.04-2.49-3.22-5.04
Capital Expenditures
-0--0.01-0.04-0.1-
Free Cash Flow
-0.76-1.03-2.05-2.53-3.31-5.04
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingJun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Gross Margin
98.12%100.00%100.00%100.00%--
Operating Margin
-2490.34%-6960.98%-52425.60%-13246.02%--
Pretax Margin
-4452.06%-20394.96%-70343.09%-26503.98%--
Profit Margin
-4452.06%-20394.96%-70343.09%-26517.21%--
FCF Margin
-820.08%-2607.67%-23132.80%-4180.05%--

Valuation
Chart
Fiscal YearCurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingSep '26 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
PS Ratio
14.46114.26581.91987.63--